• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,608.98 49.74
( 0.07%)
Global Indices
Nasdaq
49,785.17 59.69
(0.12%)
Dow Jones
7,421.51 -12.33
(-0.17%)
Hang Seng
63,198.64 456.07
(0.73%)
Nikkei 225
10,300.99 35.67
(0.35%)
Forex
USD-INR
95.14 0.72
(0.77%)
EUR-INR
111.99 0.76
(0.69%)
GBP-INR
129.47 0.85
(0.66%)
JPY-INR
0.61 0.00
(0.51%)

EQUITY - MARKET SCREENER

Infinium Pharmachem Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78690
INE0MRE01011
67.8370031
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
INFINIUM
39.78
336.6
EPS(TTM)
Face Value()
Div & Yield %
5.43
10
0
 

idfc first bank ltd
SML Mahindra gains as April sales climbs 15% YoY
May 04,2026
The company’s cargo vehicle sales increased 5% YoY to 410 units, while passenger vehicle sales rose 19% YoY to 1,331 units from 1,123 units in the year-ago period.

SML Mahindra (formerly known as SML Isuzu) is primarily engaged in the business of the manufacture and sale of commercial vehicles and their parts.

The company reported a marginal 2.36% year-on-year (YoY) rise in standalone net profit to Rs 54.20 crore for the fourth quarter ended 31st March 2026, compared with Rs 52.95 crore in the corresponding quarter last year. Revenue from operations rose 16.39% YoY to Rs 897.65 crore in the quarter ended 31 March 2026.